FDA Inspection 1009630 — Andreas Reiter, M.D.
The FDA completed an inspection of Andreas Reiter, M.D. on Jan 27, 2017 in Mannheim. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 27, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Mannheim (Germany)
Additional details
Clinical Investigator (CI)